Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making-Reference-Cited by-同舟云学术

Modeling Subpopulations with the $MIXTURE Subroutine in NONMEM: Finding the Individual Probability of Belonging to a Subpopulation for the Use in Model Analysis and Improved Decision Making

Published:2009-03 Issue:1 Volume:11 Page:148-154
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Carlsson Kristin C.,Savi Radojka M.,Hooker Andrew C.,Karlsson Mats O.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-009-9093-4.pdf

Reference11 articles.

1. L. Aarons. Software for population pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 36:255–264 (1999).

2. S. Sadray, E. N. Jonsson, and M. O. Karlsson. Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection. Pharm Res. 16:1260–1265 (1999).

3. P. H. Zingmark, M. Ekblom T. Odergren et al. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. Br. J. Clin. Pharmacol. 56:173–183 (2003).

4. R. Miller, B. Frame B. Corrigan et al. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin. Pharmacol. Ther. 73:491–505 (2003).

5. T. Tanigawa, R. Heinig, Y. Kuroki, and S. Higuchi. Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach. Drug Metab Pharmacokinet. 21:61–69 (2006).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?;Pharmaceutics;2024-07-23

2. Extension of individual model averaging assessments to unbalanced designs and dose-response;2024-04-17

3. Assessment of non-linear mixed effects model-based approaches to test for drug effect using simulated data: type I error and power properties;2024-04-17

4. Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment;Pharmaceuticals;2023-11-08

5. Pharmacometric modeling of drug adverse effects: an application of mixture models in schizophrenia spectrum disorder patients treated with clozapine;Journal of Pharmacokinetics and Pharmacodynamics;2022-11-15